Trial of Memantine for Cognitive Impairment in Multiple Sclerosis
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
This study is designed to determine whether memantine is an effective treatment for memory
and cognitive problems associated with multiple sclerosis when compared to placebo.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Oregon Health and Science University
Collaborators:
Forest Laboratories MS-Hub Seattle University of Southern California University of Texas Southwestern Medical Center